| Financial Year |
March 31 2023 |
| Monetary Funds |
58,041,983,000.00 |
| Held-for-trading Financial Assets |
3,647,000.00 |
| Notes Receivable |
4,427,363,000.00 |
| Accounts Receivable |
103,165,386,000.00 |
| Advances to Suppliers |
38,123,394,000.00 |
| Other Receivables |
48,891,945,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
13,583,000.00 |
| Dividend Receivable |
79,845,000.00 |
| Inventories |
86,189,818,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,683,367,000.00 |
| Other Current Assets |
9,077,163,000.00 |
| Total Current Assets |
487,574,573,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
37,211,399,000.00 |
| Long-term Equity Investment |
33,082,144,000.00 |
| Investment Properties |
7,843,741,000.00 |
| Fixed Assetes |
24,984,568,000.00 |
| Under-construction Projects |
4,140,314,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,104,204,000.00 |
| R&D expenses |
-- |
| Goodwill |
54,315,000.00 |
| Long-Term Deferred and Prepaid Expenses |
439,617,000.00 |
| Deferred Income Tax Assets |
6,449,733,000.00 |
| Other Non-Current Assets |
6,556,350,000.00 |
| Sub-Total of Non-Current Assets |
148,610,716,000.00 |
| Total Assets |
636,185,289,000.00 |
| Short-Term Loans |
39,852,946,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,266,395,000.00 |
| Accounts Payable |
200,976,179,000.00 |
| Accounts Received In Advance |
104,069,000.00 |
| Employee Compensation Payable |
2,285,867,000.00 |
| Taxes Payable |
4,626,719,000.00 |
| Interest Payable |
12,659,000.00 |
| Dividend Payable |
655,860,000.00 |
| Other payables |
27,393,689,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,478,860,000.00 |
| Other Current Liabilities |
16,402,624,000.00 |
| Sub-Total of Current Liabilities |
411,875,807,000.00 |
| Long-term Loans |
36,249,603,000.00 |
| Bonds Payable |
3,300,000,000.00 |
| Long-Term Accounts Payable |
1,257,288,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
994,734,000.00 |
| Deferred Income Tax Liabilities |
202,943,000.00 |
| Other Non-Current Liabilities |
460,361,000.00 |
| Sub-Total of Non-Current Liabilities |
47,606,381,000.00 |
| Total Liabilities |
459,482,188,000.00 |
| Paid-In Capital(Or Share Stock) |
20,723,619,000.00 |
| Capital Surplus |
22,588,477,000.00 |
| Surplus Reserve |
2,976,424,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
48,282,294,000.00 |
| Minority Stockholder's Interest |
34,486,694,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
142,216,407,000.00 |
| Owner's Equity（Stockholder's Equity） |
176,703,101,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
636,185,289,000.00 |
